GDTC
CYTOMED THERAPEUTICS LIMITED

273
Loading...
Loading...
News
all
press releases
CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration
SINGAPORE / ACCESSWIRE / March 20, 2024 / CytoMed Therapeutics Limited (NASDAQ:GDTC) ('CytoMed' or 'the Company'), a Singapore biopharmaceutical company that focuses on utilizing its licensed...
Accesswire·2y ago
News Placeholder
More News
News Placeholder
CytoMed Launches Shareholder Cell Banking Program
CytoMed Therapeutics Limited (GDTC) has released an update. CytoMed Therapeutics Limited announces a pilot program offering free cell banking to it...
TipRanks Financial Blog·2y ago
News Placeholder
Cytomed Therapeutics to launch complimentary cell banking
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ( CytoMed or Company ), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
Globe Newswire·2y ago
News Placeholder
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
CytoMed diversifies into regenerative medicineSINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ( CytoMed or Company ), a Singapore-based biopharmaceutical...
Globe Newswire·2y ago
News Placeholder
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
The Company now has exclusive rights to a Malaysia, US and China patentSINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ( CytoMed or Company ), a...
Globe Newswire·2y ago

Latest GDTC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.